-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
MERS-CoV-IN-1
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2245697-92-9.gif)
| Category | SARS-CoV |
| CAS | 2245697-92-9 |
| Description | MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus, which has the potential for COVID-19 research. |
Product Information
| Synonyms | 2-((4-phenoxyphenoxy)methyl)aniline |
| IUPAC Name | 2-[(4-phenoxyphenoxy)methyl]aniline |
| Molecular Weight | 291.34 |
| Molecular Formula | C19H17NO2 |
| Canonical SMILES | C1=CC=C(C=C1)OC2=CC=C(C=C2)OCC3=CC=CC=C3N |
| InChI | InChI=1S/C19H17NO2/c20-19-9-5-4-6-15(19)14-21-16-10-12-18(13-11-16)22-17-7-2-1-3-8-17/h1-13H,14,20H2 |
| InChIKey | OQSQUIZZPAFLIO-UHFFFAOYSA-N |
| Purity | 98% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | White to off-white (Solid) |
| Storage | Store at 2-8°C |
| Complexity | 309 |
| Exact Mass | 291.125928785 |
| Target | MERS-CoV and SARS |
| XLogP3-AA | 4.2 |
